These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28877926)

  • 1. Effectiveness of Quality Improvement Strategies for the Management of CKD: A Meta-Analysis.
    Silver SA; Bell CM; Chertow GM; Shah PS; Shojania K; Wald R; Harel Z
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1601-1614. PubMed ID: 28877926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.
    Navaneethan SD; Jolly SE; Schold JD; Arrigain S; Nakhoul G; Konig V; Hyland J; Burrucker YK; Dann PD; Tucky BH; Sharp J; Nally JV
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1418-1427. PubMed ID: 28778854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans.
    Lunyera J; Davenport CA; Bhavsar NA; Sims M; Scialla J; Pendergast J; Hall R; Tyson CC; Russell JSC; Wang W; Correa A; Boulware LE; Diamantidis CJ
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):213-222. PubMed ID: 29298761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Metabolomic Alterations Associated with Proteinuria in CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Appel LJ; Chen J; Vasan RS; Anderson AH; Feldman HI; Kimmel PL; Waikar SS; Köttgen A; Evans AM; Levey AS; Inker LA; Sarnak MJ; Grams ME;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):342-353. PubMed ID: 30733224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Analysis of Quality Indicators in CKD.
    Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
    Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone antagonists for preventing the progression of chronic kidney disease.
    Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension: A Pragmatic Cluster-Randomized Trial.
    Peralta CA; Frigaard M; Rolon L; Seal K; Tuot D; Senyak J; Lo L; Powe N; Scherzer R; Chao S; Chiao P; Lui K; Shlipak MG; Rubinsky AD
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):174-181. PubMed ID: 32034070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.
    Tangkiatkumjai M; Walker DM; Praditpornsilpa K; Boardman H
    Clin Exp Nephrol; 2017 Jun; 21(3):504-512. PubMed ID: 27438073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis.
    Tricco AC; Ivers NM; Grimshaw JM; Moher D; Turner L; Galipeau J; Halperin I; Vachon B; Ramsay T; Manns B; Tonelli M; Shojania K
    Lancet; 2012 Jun; 379(9833):2252-61. PubMed ID: 22683130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.
    Hayashi T; Maruyama S; Nangaku M; Narita I; Hirakata H; Tanabe K; Morita S; Tsubakihara Y; Imai E; Akizawa T;
    Clin J Am Soc Nephrol; 2020 May; 15(5):608-615. PubMed ID: 32245781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Person-Centered Integrated Care for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Valentijn PP; Pereira FA; Ruospo M; Palmer SC; Hegbrant J; Sterner CW; Vrijhoef HJM; Ruwaard D; Strippoli GFM
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):375-386. PubMed ID: 29438975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD.
    Muanda FT; Weir MA; Bathini L; Clemens KK; Perkovic V; Sood MM; McArthur E; Sontrop JM; Kim RB; Garg AX
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1728-1739. PubMed ID: 33239410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
    Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
    Trivin C; Metzger M; Haymann JP; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Stengel B; Thervet E;
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):957-64. PubMed ID: 25979978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.